Patents-Review.com
ClassID:

96775 ⎘

C07K14/03 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses; DNA viruses Herpetoviridae, e.g. pseudorabies virus

Sub-classes:
Recent Application in this class:
#1
20260132171
2026-05-14

PRE-FUSION-STABILIZED CMV GB PROTEIN NANOSTRUCTURES

 #2
20260092256
2026-04-02

PEPMIXES TO GENERATE MULTIVIRAL CTLS WITH BROAD SPECIFICITY

 #3
20250333766
2025-10-30

RECOMBINANT HVT VECTORS EXPRESSING MULTIPLE ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF

 #4
20240207393
2024-06-27

Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy

 #5
20230175017
2023-06-08

RECOMBINANT HVT VECTORS EXPRESSING MULTIPLE ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF

 #6
20220251508
2022-08-11

Pepmixes to generate multiviral CTLS with broad specificity

 #7
20220072084
2022-03-10

THERAPEUTIC NANOCONJUGATES AND USES THEREOF

 #8
20220062410
2022-03-03

Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy

 #9
20210403861
2021-12-30

NUCLEOTIDE-SPECIFIC RECOGNITION SEQUENCES FOR DESIGNER TAL EFFECTORS

 #10
20210348127
2021-11-11

Pepmixes to generate multiviral CTLs with broad specificity

 #11
20210322473
2021-10-21

MODIFIED T CELLS AND METHODS OF THEIR USE

 #12
20210122788
2021-04-29

Compositions and methods for treating autoimmune and inflammatory disorders

 #13
20210010033
2021-01-14

Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof

 #14
20200071363
2020-03-05

ANIMAL MODEL OF A MOOD DISORDER AND SCREENING METHOD

 #15
20200054736
2020-02-20

Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy

 #16
20190249196
2019-08-15

Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof

 #17
20190119329
2019-04-25

Compositions and methods for treating autoimmune and inflammatory disorders

 #18
20190025306
2019-01-24

Enzyme-linked immunoassay to detect gammaherpesvirus 1

 #19
20190002824
2019-01-03

Nucleotide-specific recognition sequences for designer TAL effectors

 #20
20180163230
2018-06-14

Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof

 #21
20180008695
2018-01-11

THERAPEUTIC VACCINES FOR TREATING HERPES SIMPLEX VIRUS TYPE-2 INFECTIONS

 #22
20170190745
2017-07-06

Factor involved in latent infection with herpes virus, and use thereof

 #23
20140193483
2014-07-10

Therapeutic vaccines for treating herpes simplex virus type-2 infections

 #24
20130216613
2013-08-22

CYTOMEGALOVIRUS GB ANTIGEN

 #25
20130164306
2013-06-27

Compositions and methods for treating autoimmune and inflammatory disorders

 #26
20130137174
2013-05-30

Nucleotide-specific recognition sequences for designer TAL effectors

 #27
20130137161
2013-05-30

Nucleotide-Specific Recognition Sequences For Designer TAL Effectors

 #28
20130137160
2013-05-30

Nucleotide-specific recognition sequences for designer TAL effectors

 #29
20130137088
2013-05-30

Factor involved in latent infection with herpesvirus, and use thereof

 #30
20100281550
2010-11-04

Diagnosis of mood disorders by detecting latent infection with human herpesvirus-6